Abstract
Objective
Methods
Results
Notes
Conceptualization: Lee SJ, Ko HY. Methodology: Lee SJ, Huh SC, Ko SH. Formal analysis: Lee SJ, Ko HY. Funding acquisition: Ko HY. Project administration: Lee SJ, Huh SC, Ko SH, Min JH, Ko HY. Visualization: Lee SJ, Huh SC, Ko SH, Min JH, Ko HY. Writing – original draft: Lee SJ, Ko HY. Writing - review and editing: Lee SJ, Ko HY. Approval of final manuscript: all authors.
REFERENCES
Table 1.
Table 2.
Pulmonary function parameters |
PAS |
PRG |
||
---|---|---|---|---|
Correlation coefficients | p-value | Correlation coefficients | p-value | |
TV | -0.243 | 0.032* | -0.275 | 0.015* |
FVC | -0.441 | 0.000* | -0.432 | 0.000* |
FEV1 | -0.470 | 0.000* | -0.543 | 0.000* |
MIP | -0.394 | 0.000* | -0.430 | 0.000* |
MEP | -0.363 | 0.001* | -0.294 | 0.009* |
PCF | -0.488 | 0.000* | -0.484 | 0.000* |
Table 3.
Variable | Penetration-aspiration (n=40) | Non-penetration- aspiration (n=38) | p-value |
Multivariate analysis |
|
---|---|---|---|---|---|
β coefficient | p-value | ||||
Age (yr) | 64.03±11.08 | 52.89±17.36 | 0.001* | 0.279 | 0.002* |
Sex | 0.083 | - | |||
Male | 38 (95.0) | 31 (81.6) | |||
Female | 2 (5.0) | 7 (18.4) | |||
Tracheostomy | 0.001* | 0.085 | 0.392 | ||
Positive | 26 (65.0) | 11 (28.95) | |||
Negative | 14 (35.0) | 27 (71.05) | |||
Surgery | 0.005* | 0.349 | 0.000* | ||
Anterior approach | 22 (55.0) | 9 (23.68) | |||
Others | 18 (45.0) | 29 (86.32) | |||
Neurological level of injury | 0.01* | 0.242 | 0.012* | ||
Upper (C1–C4) | 32 (80.0) | 20 (52.63) | |||
Lower (C5–C8) | 8 (20.0) | 18 (47.37) | |||
ASIA impairment scale | 0.375 | - | |||
A | 21 (52.5) | 16 (42.11) | |||
B, C, or D | 19 (47.5) | 22 (57.89) | |||
TV (L) | 0.43±0.16 | 0.47±0.16 | 0.248 | - | |
FVC (%pred) | 40.63±22.85 | 48.96±24.06 | 0.004* | 0.181 | 0.294 |
FEV1 (%pred) | 39.42±28.59 | 47.52±29.01 | 0.000* | -0.187 | 0.308 |
MIP (cmH2O) | 25.73±19.88 | 48.68±29.56 | 0.000* | 0.020 | 0.901 |
MEP (cmH2O) | 20.28±17.82 | 41.39±31.71 | 0.001* | -0.061 | 0.682 |
PCF (L/min) | 107.25±87.06 | 215.79±123.39 | 0.000* | -0.398 | 0.017* |
Values are presented as mean±standard deviation or number (%).
ASIA, American Spinal Injury Association; %pred, percentage of predicted normal; TV, tidal volume; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure; PCF, peak cough flow.
Table 4.
Variable | Pharyngeal residue group (n=37) | Non-pharyngeal reside group (n=41) | p-value |
Multivariate analysis |
|
---|---|---|---|---|---|
β coefficient | p-value | ||||
Age (yr) | 64.24±13.16 | 53.51±15.71 | 0.002* | 0.279 | 0.002* |
Sex | 0.487 | - | |||
Male | 34 (94.89) | 35 (85.37) | |||
Female | 3 (8.11) | 6 (14.63) | |||
Tracheostomy | 0.001* | 0.144 | 0.154 | ||
Positive | 25 (67.57) | 12 (29.27) | |||
Negative | 12 (32.43) | 29 (70.73) | |||
Surgery | 0.001* | 0.403 | 0.000* | ||
Anterior approach | 22 (59.46) | 9 (21.95) | |||
Others | 15 (40.54) | 32 (78.05) | |||
AIS level of injury | 0.01* | 0.233 | 0.016* | ||
Upper (C1–C4) | 30 (81.08) | 22 (53.66) | |||
Lower (C5–C8) | 7 (18.92) | 19 (46.34) | |||
ASIA impairment scale | 0.173 | - | |||
A | 21 (56.76) | 16 (39.02) | |||
B, C, or D | 16 (43.24) | 25 (60.98) | |||
TV (L) | 0.42±0.17 | 0.48±0.15 | 0.070 | - | |
FVC (%pred) | 37.66±24.07 | 49.55±23.82 | 0.000* | -0.090 | 0.604 |
FEV1 (%pred) | 36.28±27.05 | 48.03±28.85 | 0.000* | -0.206 | 0.026* |
MIP (cmH2O) | 25.51±21.97 | 47.20±28.06 | 0.000* | -0.105 | 0.518 |
MEP (cmH2O) | 22.70±22.99 | 37.66±29.55 | 0.016* | 0.136 | 0.364 |
PCF (L/min) | 110.00±102.25 | 205.37±115.67 | 0.000* | -0.110 | 0.503 |
Values are presented as mean±standard deviation or number (%).
ASIA, American Spinal Injury Association; %pred, percentage of predicted normal; TV, tidal volume; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure; PCF, peak cough flow.